Web Version

Circulating cell-free DNA (cfDNA) and RNA (cfRNA) can provide critical information on diseases that are normally difficult to detect with standard approaches. As a consequence, interest in liquid biopsy methods for biomarker discovery and disease research is on the rise. Another rich source of biomarkers that are amenable to the straightforward liquid biopsy approach are exosomes.

To facilitate biomarker discovery in liquid biopsies, BioCat offers comprehensive tools for the complete workflow from the collection and preservation of blood or urine through the enrichment and purification of cfDNA, cfRNA and exosomal RNA.

Biomarker Discovery in Blood and Urine 10% OFF

  • Blood & Urine Collection and Preservation
  • Circulating cell-free DNA Isolation
  • Circulating cell-free RNA Isolation
  • Exosome Isolation
  • Exosomal RNA Isolation
BioCat GmbH

Im Neuenheimer Feld 584
D-69120 Heidelberg
Tel:  +49 (0) 6221 7141516
Fax: +49 (0) 6221 7141529
Email: info@biocat.com
Web: https://www.biocat.com